Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Stride management assist exoskeleton vs functional gait training in stroke: A randomized trial.

Jayaraman A, O'Brien MK, Madhavan S, Mummidisetty CK, Roth HR, Hohl K, Tapp A, Brennan K, Kocherginsky M, Williams KJ, Takahashi H, Rymer WZ.

Neurology. 2019 Jan 15;92(3):e263-e273. doi: 10.1212/WNL.0000000000006782. Epub 2018 Dec 19.

PMID:
30568009
2.

No relevant pharmacokinetic drug-drug interaction between nintedanib and pirfenidone.

Richeldi L, Fletcher S, Adamali H, Chaudhuri N, Wiebe S, Wind S, Hohl K, Baker A, Schlenker-Herceg R, Stowasser S, Maher TM.

Eur Respir J. 2019 Jan 10;53(1). pii: 1801060. doi: 10.1183/13993003.01060-2018. Print 2019 Jan.

PMID:
30442716
3.

Optimization of a drug transporter probe cocktail: potential screening tool for transporter-mediated drug-drug interactions.

Stopfer P, Giessmann T, Hohl K, Hutzel S, Schmidt S, Gansser D, Ishiguro N, Taub ME, Sharma A, Ebner T, Müller F.

Br J Clin Pharmacol. 2018 Sep;84(9):1941-1949. doi: 10.1111/bcp.13609. Epub 2018 Jun 21.

4.

Effects of Metformin and Furosemide on Rosuvastatin Pharmacokinetics in Healthy Volunteers: Implications for Their Use as Probe Drugs in a Transporter Cocktail.

Stopfer P, Giessmann T, Hohl K, Sharma A, Ishiguro N, Taub ME, Jungnik A, Gansser D, Ebner T, Müller F.

Eur J Drug Metab Pharmacokinet. 2018 Feb;43(1):69-80. doi: 10.1007/s13318-017-0427-9.

5.

The "Golden Thread": Coercive Control and Risk Assessment for Domestic Violence.

Myhill A, Hohl K.

J Interpers Violence. 2016 Oct 1:886260516675464. doi: 10.1177/0886260516675464. [Epub ahead of print]

PMID:
27807208
6.

Pharmacokinetic Evaluation of a Drug Transporter Cocktail Consisting of Digoxin, Furosemide, Metformin, and Rosuvastatin.

Stopfer P, Giessmann T, Hohl K, Sharma A, Ishiguro N, Taub ME, Zimdahl-Gelling H, Gansser D, Wein M, Ebner T, Müller F.

Clin Pharmacol Ther. 2016 Sep;100(3):259-67. doi: 10.1002/cpt.406. Epub 2016 Jul 29.

7.

[Heart failure as a predictor of functional dependence in hospitalized elderly].

Xavier Sde O, Ferretti-Rebustini RE, Santana-Santos E, Lucchesi PA, Hohl KG.

Rev Esc Enferm USP. 2015 Oct;49(5):790-6. doi: 10.1590/S0080-623420150000500012. Portuguese.

8.

Crystal Structure of the Human Cytomegalovirus pUL50-pUL53 Core Nuclear Egress Complex Provides Insight into a Unique Assembly Scaffold for Virus-Host Protein Interactions.

Walzer SA, Egerer-Sieber C, Sticht H, Sevvana M, Hohl K, Milbradt J, Muller YA, Marschall M.

J Biol Chem. 2015 Nov 13;290(46):27452-8. doi: 10.1074/jbc.C115.686527. Epub 2015 Oct 2.

9.

Relative bioavailability study of linagliptin/metformin tablets in healthy Chinese subjects.

Pichereau S, Zhao X, Cui Y, Zhao S, Hohl K, Meinicke T, Friedrich C.

Int J Clin Pharmacol Ther. 2015 Jul;53(7):582-92. doi: 10.5414/CP202237.

PMID:
26073354
10.

Indirect bioequivalence assessment using network meta-analyses.

Ring A, Morris TB, Hohl K, Schall R.

Eur J Clin Pharmacol. 2014 Aug;70(8):947-55. doi: 10.1007/s00228-014-1691-0. Epub 2014 May 20.

PMID:
24838637
11.

Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials.

Metzmann K, Schnell D, Jungnik A, Ring A, Theodor R, Hohl K, Meinicke T, Friedrich C.

Int J Clin Pharmacol Ther. 2014 Jul;52(7):549-63. doi: 10.5414/CP201961.

PMID:
24755124
12.

Effect of food on the pharmacokinetics of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, and assessment of dose proportionality in healthy volunteers.

Macha S, Jungnik A, Hohl K, Hobson D, Salsali A, Woerle HJ.

Int J Clin Pharmacol Ther. 2013 Nov;51(11):873-9.

PMID:
24152604
13.

Training effects of combined resistance and proprioceptive neck muscle exercising.

Kramer M, Hohl K, Bockholt U, Schneider F, Dehner C.

J Back Musculoskelet Rehabil. 2013;26(2):189-97. doi: 10.3233/BMR-130368.

PMID:
23640321
14.

The need for pressure changes in CPAP therapy 2-3 months after initial treatment: a prospective trial in 905 patients with sleep-disordered breathing.

Netzer NC, Juhász J, Hofmann M, Hohl K, Strohl KP, Küpper TE.

Sleep Breath. 2011 Jan;15(1):107-12. doi: 10.1007/s11325-010-0332-9. Epub 2010 Mar 4.

PMID:
20204534
15.

Multidetector computed tomography coronary angiography: sublingual nitroglycerine improves image quality significantly because of peripheral coronary vasodilatation.

Klass O, Mutlu S, Hohl K, Feuerlein S, Jeltsch M, Brambs HJ, Hoffmann MH.

J Comput Assist Tomogr. 2009 Mar-Apr;33(2):199-203. doi: 10.1097/RCT.0b013e31817c6b33.

PMID:
19346845
16.

The weak evidence base for antibiotic prophylaxis in severe acute pancreatitis.

Wittau M, Hohl K, Mayer J, Henne-Bruns D, Isenmann R.

Hepatogastroenterology. 2008 Nov-Dec;55(88):2233-7.

PMID:
19260512
17.

[(11)C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy.

Rinnab L, Simon J, Hautmann RE, Cronauer MV, Hohl K, Buck AK, Reske SN, Mottaghy FM.

World J Urol. 2009 Oct;27(5):619-25. doi: 10.1007/s00345-009-0371-7. Epub 2009 Feb 21.

PMID:
19234708
18.

Reliability of a new virtual reality test to measure cervicocephalic kinaesthesia.

Kramer M, Honold M, Hohl K, Bockholt U, Rettig A, Elbel M, Dehner C.

J Electromyogr Kinesiol. 2009 Oct;19(5):e353-61. doi: 10.1016/j.jelekin.2008.05.005. Epub 2008 Aug 5.

PMID:
18684641
19.

European public perceptions of food risk: cross-national and methodological comparisons.

Hohl K, Gaskell G.

Risk Anal. 2008 Apr;28(2):311-24. doi: 10.1111/j.1539-6924.2008.01021.x.

PMID:
18419651
20.

Choosing the optimal fit function: comparison of the Akaike information criterion and the F-test.

Glatting G, Kletting P, Reske SN, Hohl K, Ring C.

Med Phys. 2007 Nov;34(11):4285-92.

PMID:
18072493
21.

Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer.

Rinnab L, Mottaghy FM, Blumstein NM, Reske SN, Hautmann RE, Hohl K, Möller P, Wiegel T, Kuefer R, Gschwend JE.

BJU Int. 2007 Oct;100(4):786-93.

22.

11C-choline positron-emission tomography/computed tomography and transrectal ultrasonography for staging localized prostate cancer.

Rinnab L, Blumstein NM, Mottaghy FM, Hautmann RE, Küfer R, Hohl K, Reske SN.

BJU Int. 2007 Jun;99(6):1421-6. Epub 2007 Mar 12.

23.

Improved non-invasive T-Staging in non-small cell lung cancer by integrated 18F-FDG PET/CT.

Pauls S, Buck AK, Hohl K, Halter G, Hetzel M, Blumstein NM, Mottaghy FM, Glatting G, Krüger S, Sunder-Plassmann L, Möller P, Hombach V, Brambs HJ, Reske SN.

Nuklearmedizin. 2007;46(1):9-14; quiz N1-2.

PMID:
17299649
24.

Anti-CD45 monoclonal antibody YAML568: A promising radioimmunoconjugate for targeted therapy of acute leukemia.

Glatting G, Müller M, Koop B, Hohl K, Friesen C, Neumaier B, Berrie E, Bird P, Hale G, Blumstein NM, Waldmann H, Bunjes D, Reske SN.

J Nucl Med. 2006 Aug;47(8):1335-41.

25.

[The indications and the efficiency of x-ray therapy of the eyelid tumours (author's transl)].

Hohl K.

Klin Monbl Augenheilkd. 1979 Jun;174(6):916-21. German.

PMID:
90183
26.

[New aspects in the treatment of breast cancer (author's transl)].

Hohl K.

Radiol Clin (Basel). 1975;44(4):309-18. German.

PMID:
1197673
27.

[Statistics of results with malignant lymphomas at St. Gallen].

Hohl K.

Radiol Clin Biol. 1973;42(4):298-307. German. No abstract available.

PMID:
4579925
28.

[Correlation between radiation reaction and tumour regression in carcinoma of the tongue].

Hohl K.

Radiol Clin Biol. 1971;40(6):374-81. German. No abstract available.

PMID:
5119078
29.

[Radiotherapy of Bechterew's disease (spondylitis ankylopoetica)].

Hohl K.

Praxis. 1969 May 6;58(18):579-85. German. No abstract available.

PMID:
5819315
30.

[Implantation treatment with solid radioisotopes].

Hohl K.

Radiol Clin Biol. 1966;35(6):419-44. German. No abstract available.

PMID:
5969230
31.
32.

[CURRENT STATUS OF THERAPY AND PROGNOSIS OF LYMPHOGRANULOMATOSIS].

HOHL K.

Radiol Clin. 1964;33:273-86. German. No abstract available.

PMID:
14242601
33.

[CURRENT STATUS OF THERAPY AND PROGNOSIS OF LYMPHOGRANULOMATOSIS].

HOHL K.

Radiol Clin. 1964;33:273-86. German. No abstract available.

PMID:
14234358
34.

[Diabetes and the spine].

FREHNER HU, HOHL K.

Helv Med Acta. 1961 Sep;28:502-5. German. No abstract available.

PMID:
13894946
35.

[New viewpoints regarding radiotherapy of Hodgkin's disease].

HOHL K.

Schweiz Med Wochenschr. 1961 Jan 7;91:25-6. German. No abstract available.

PMID:
13715167
36.

[What are the effects of the implantation of Au-198 seeds in cancer therapy?].

HOHL K.

Radiol Clin. 1960 Sep;29:298-309. German. No abstract available.

PMID:
13715168
37.

[Spinal degeneration; reduction of roentgen dosage in patients' examinations].

HOHL K.

Radiol Clin. 1958 Nov;27(6):365-72. German. No abstract available.

PMID:
13614657
38.

[Contribution to the differential diagnosis of choroidal tumors].

BANGERTER A, HOHL K.

Schweiz Med Wochenschr. 1957 Sep 21;87(38):1195-8. French, German. No abstract available.

PMID:
13485977
39.

[Reticulosarcoma; materials from Zurich, 1936-51 (39 cases)].

HOHL K, GRETENER A.

Oncologia. 1956;9(3):338-52. German. No abstract available.

PMID:
13349085
40.

[Pathological changes of the skeletal system with special reference to jaws and teeth, exclusive of inflammatory and neoplastic affections].

HOHL K.

SSO Schweiz Monatsschr Zahnheilkd. 1955 Oct;65(10):969-74. German. No abstract available.

PMID:
13281512
41.

[Radiation hazards and protection in dental radiography and radioscopy apparatus].

HOHL K.

SSO Schweiz Monatsschr Zahnheilkd. 1955 Oct;65(10):959-63. German. No abstract available.

PMID:
13281510
42.

[Maximum charge of the skin in deep therapy in relation to the area surface; a law of roentgenotherapy].

HOHL K, JOYET G.

Radiol Clin. 1955 Sep;24(5):310-6. French. No abstract available.

PMID:
13280867
43.

[Biological skin reaction in deep therapy as a function of size of the field; a law for radiotherapy].

JOYET G, HOHL K.

Fortschr Geb Rontgenstr. 1955 Mar;82(3):387-400. German. No abstract available.

PMID:
14380514
44.

[Therapy and prognosis of malignoma of oral cavity with tongue excision; report of 155 cases from the Clinic in Zürich].

HOHL K.

Oncologia. 1954;7(3):193-222. Undetermined Language. No abstract available.

PMID:
13185590
45.

[Experiences in Zürich with clinical application of radiophosphorus, radioiodine and radiogold].

HOHL K.

Oncologia. 1954;7(2):106-26. Undetermined Language. No abstract available.

PMID:
13166200
46.

[Screen irradiation].

HOHL K.

Radiol Clin. 1953 Nov;22(6):486-91. Undetermined Language. No abstract available.

PMID:
13134477
47.

[Treatment and prognosis of seminoma; Zurich statistics on 48 cases observed during the period 1925-49].

HOHL K.

Oncologia. 1953;6(3):195-205. Undetermined Language. No abstract available.

PMID:
13073157
48.

[Problems and progress in therapy of deep tumors].

HOHL K.

Schweiz Med Wochenschr. 1951 Dec 8;81(49):1219-23. Undetermined Language. No abstract available.

PMID:
14913071
49.

[Treatment and prognosis of malignancies of the tongue, with reference to 221 cases treated in Zürich during the period 1919-48].

HOHL K.

Oncologia. 1951-1952;4(4):208-26. Undetermined Language. No abstract available.

PMID:
14941609
50.

[Therapy and prognosis of Hodgkin's disease; cases in Zurich 1922-50].

HOHL K, SARASIN P, BESSLER W.

Oncologia. 1951;4(1):1-20. Undetermined Language. No abstract available.

PMID:
14853449

Supplemental Content

Support Center